ALBO logo

Albireo Pharma (ALBO) Cash From Investing

Annual CFI

$102.92 M
+$103.00 M+132051.28%

December 31, 2021

Summary

Performance

1-Year Change

+132051.28%

3-Year Change

+219082.98%

5-Year Change

+2287.98%

15-Year Change

+2287.98%

ALBO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$102.92 M
ALBO annual cash flow from investing activities is currently at an all-time high

3-Year Low

$102.92 M
ALBO annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
ALBO previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
ALBO next annual earnings announcement has not yet been scheduled

OtherALBOcash flowmetrics:

Annual CFF

$2.76 M
ALBO annual cash flow from financing activities is $2.76 million

Annual CFO

-$107.56 M
ALBO annual cash flow from operations is -$107.56 million

Annual FCF

-$108.02 M
ALBO annual free cash flow is -$108.02 million

Annual CAPEX

$465.00 K
ALBO annual capital expenditures is $465.00 thousand

Quarterly CFI

-$40.00 K
+$645.00 K+94.16%

September 30, 2022

Summary

Performance

3-Month Change

+94.16%

1-Year Change

-100.04%

3-Year Change

+64.91%

5-Year Change

+2.44%

ALBO Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$103.20 M
ALBO quarterly cash flow from investing activities is currently -100.04% below its historical high of $103.20 million

3-Year Low

-$685.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
ALBO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
ALBO next earnings announcement has not yet been scheduled

OtherALBOcash flowmetrics:

Quarterly CFF

$121.48 M
ALBO quarterly cash flow from financing activities is $121.48 million

Quarterly CFO

-$29.63 M
ALBO quarterly cash flow from operations is -$29.63 million

Quarterly FCF

-$29.67 M
ALBO quarterly free cash flow is -$29.67 million

Quarterly CAPEX

$40.00 K
ALBO quarterly capital expenditures is $40.00 thousand

TTM CFI

-$960.00 K
-$103.24 M-100.94%

September 30, 2022

Summary

Performance

3-Month Change

-100.94%

1-Year Change

-100.93%

3-Year Change

-77.78%

5-Year Change

-77.78%

ALBO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$102.92 M
ALBO TTM cash flow from investing activities is currently -100.93% below its historical high of $102.92 million

3-Year Low

-$960.00 K
ALBO TTM cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
ALBO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
ALBO next earnings announcement has not yet been scheduled

OtherALBOcash flowmetrics:

TTM CFF

$128.04 M
ALBO TTM cash flow from financing activities is $128.04 million

TTM CFO

-$115.32 M
ALBO TTM cash flow from operations is -$115.32 million

TTM FCF

-$116.28 M
ALBO TTM free cash flow is -$116.28 million

TTM CAPEX

$960.00 K
ALBO TTM capital expenditures is $960.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ALBO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10000.0%-100.0%-100.9%
3 y3 years+10000.0%+64.9%-77.8%
5 y5 years+2288.0%+2.4%-77.8%

ALBO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low<-9999.0%+1612.5%-100.9%at low
5 y5-yearat high-100.5%-100.0%+1612.5%-100.9%at low
alltimeall timeat high-127.6%-100.0%>+9999.0%-100.9%+3429.2%

Albireo Pharma Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2022
-
-$40.00 K(-94.2%)
-$960.00 K(-100.9%)
Jun 2022
-
-$685.00 K(+191.5%)
$102.28 M(-0.4%)
Mar 2022
-
-$235.00 K(<-9900.0%)
$102.69 M(-0.2%)
Dec 2021
$102.92 M(<-9900.0%)
$0.00(-100.0%)
$102.92 M(0.0%)
Sep 2021
-
$103.20 M(<-9900.0%)
$102.92 M(<-9900.0%)
Jun 2021
-
-$279.00 K(<-9900.0%)
-$279.00 K(+257.7%)
Mar 2021
-
$0.00(0.0%)
-$78.00 K(0.0%)
Dec 2020
-$78.00 K(-85.6%)
$0.00(0.0%)
-$78.00 K(-17.9%)
Sep 2020
-
$0.00(-100.0%)
-$95.00 K(-54.5%)
Jun 2020
-
-$78.00 K(+358.8%)
-$209.00 K(-61.3%)
Dec 2019
-$540.00 K(+1048.9%)
-$17.00 K(-85.1%)
-$540.00 K(+3.3%)
Sep 2019
-
-$114.00 K(-72.1%)
-$523.00 K(+32.4%)
Jun 2019
-
-$409.00 K(<-9900.0%)
-$395.00 K(+740.4%)
Dec 2018
-$47.00 K(-101.1%)
$0.00(-100.0%)
-$47.00 K(-101.1%)
Sep 2018
-
$14.00 K(-200.0%)
$4.45 M(+1.3%)
Jun 2018
-
-$14.00 K(-70.2%)
$4.39 M(+0.8%)
Mar 2018
-
-$47.00 K(-101.0%)
$4.36 M(+1.1%)
Dec 2017
$4.31 M(-83.1%)
$4.50 M(<-9900.0%)
$4.31 M(-2404.8%)
Sep 2017
-
-$41.00 K(-19.6%)
-$187.00 K(+28.1%)
Jun 2017
-
-$51.00 K(-46.3%)
-$146.00 K(-404.2%)
Mar 2017
-
-$95.00 K(<-9900.0%)
$48.00 K(-88.1%)
Dec 2016
$25.48 M(+6206.9%)
-
-
Sep 2016
-
$0.00(-100.0%)
$404.00 K(-12.0%)
Sep 2016
$404.00 K(+5671.4%)
-
-
Jun 2016
-
$143.00 K(-45.2%)
$459.00 K(+59.9%)
Mar 2016
-
$261.00 K(+374.5%)
$287.00 K(+4000.0%)
Sep 2015
$7000.00(-114.3%)
$55.00 K(-289.7%)
$7000.00(-110.8%)
Jun 2015
-
-$29.00 K(+52.6%)
-$65.00 K(+80.6%)
Mar 2015
-
-$19.00 K(+11.8%)
-$36.00 K(-26.5%)
Sep 2014
-$49.00 K
-$17.00 K(<-9900.0%)
-$49.00 K(-22.2%)
Jun 2014
-
$0.00(-100.0%)
-$63.00 K(0.0%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$26.00 K(+333.3%)
-$63.00 K(+70.3%)
Dec 2013
-
-$6000.00(-80.6%)
-$37.00 K(-68.6%)
Sep 2013
-$118.00 K(+100.0%)
-$31.00 K(<-9900.0%)
-$118.00 K(-19.2%)
Jun 2013
-
$0.00(0.0%)
-$146.00 K(+4.3%)
Mar 2013
-
$0.00(-100.0%)
-$140.00 K(-4.1%)
Dec 2012
-
-$87.00 K(+47.5%)
-$146.00 K(+147.5%)
Sep 2012
-$59.00 K(-101.0%)
-$59.00 K(-1083.3%)
-$59.00 K(+126.9%)
Jun 2012
-
$6000.00(-200.0%)
-$26.00 K(-79.8%)
Mar 2012
-
-$6000.00(<-9900.0%)
-$129.00 K(+4.9%)
Dec 2011
-
$0.00(-100.0%)
-$123.00 K(-102.1%)
Sep 2011
$5.81 M(-192.4%)
-$26.00 K(-73.2%)
$5.81 M(+1.5%)
Jun 2011
-
-$97.00 K(<-9900.0%)
$5.72 M(-1934.6%)
Mar 2011
-
$0.00(-100.0%)
-$312.00 K(-1.9%)
Dec 2010
-
$5.93 M(-5351.3%)
-$318.00 K(-94.9%)
Sep 2010
-$6.29 M(-125.2%)
-$113.00 K(-98.2%)
-$6.29 M(+11.5%)
Jun 2010
-
-$6.13 M(>+9900.0%)
-$5.64 M(-149.5%)
Mar 2010
-
-$6000.00(-85.0%)
$11.41 M(-34.5%)
Dec 2009
-
-$40.00 K(-107.5%)
$17.43 M(-30.2%)
Sep 2009
$24.98 M(-187.9%)
$534.00 K(-95.1%)
$24.98 M(-14.7%)
Jun 2009
-
$10.93 M(+81.9%)
$29.27 M(-417.7%)
Mar 2009
-
$6.01 M(-20.0%)
-$9.21 M(-53.5%)
Dec 2008
-
$7.51 M(+55.5%)
-$19.84 M(-30.2%)
Sep 2008
-$28.40 M(+1956.5%)
$4.83 M(-117.5%)
-$28.40 M(-16.2%)
Jun 2008
-
-$27.56 M(+497.3%)
-$33.88 M(+427.0%)
Mar 2008
-
-$4.61 M(+337.8%)
-$6.43 M(+201.4%)
Dec 2007
-
-$1.05 M(+61.9%)
-$2.13 M(+54.5%)
Sep 2007
-$1.38 M(+305.0%)
-$651.00 K(+491.8%)
-$1.38 M(+89.2%)
Jun 2007
-
-$110.00 K(-65.4%)
-$730.00 K(+17.7%)
Mar 2007
-
-$318.00 K(+5.3%)
-$620.00 K(+105.3%)
Dec 2006
-
-$302.00 K
-$302.00 K
Sep 2006
-$341.00 K(-42.7%)
-
-
Sep 2005
-$595.00 K
-
-

FAQ

  • What is Albireo Pharma annual cash flow from investing activities?
  • What is the all time high annual CFI for Albireo Pharma?
  • What is Albireo Pharma annual CFI year-on-year change?
  • What is Albireo Pharma quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Albireo Pharma?
  • What is Albireo Pharma quarterly CFI year-on-year change?
  • What is Albireo Pharma TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Albireo Pharma?
  • What is Albireo Pharma TTM CFI year-on-year change?

What is Albireo Pharma annual cash flow from investing activities?

The current annual CFI of ALBO is $102.92 M

What is the all time high annual CFI for Albireo Pharma?

Albireo Pharma all-time high annual cash flow from investing activities is $102.92 M

What is Albireo Pharma annual CFI year-on-year change?

Over the past year, ALBO annual cash flow from investing activities has changed by +$103.00 M (+132051.28%)

What is Albireo Pharma quarterly cash flow from investing activities?

The current quarterly CFI of ALBO is -$40.00 K

What is the all time high quarterly CFI for Albireo Pharma?

Albireo Pharma all-time high quarterly cash flow from investing activities is $103.20 M

What is Albireo Pharma quarterly CFI year-on-year change?

Over the past year, ALBO quarterly cash flow from investing activities has changed by -$103.24 M (-100.04%)

What is Albireo Pharma TTM cash flow from investing activities?

The current TTM CFI of ALBO is -$960.00 K

What is the all time high TTM CFI for Albireo Pharma?

Albireo Pharma all-time high TTM cash flow from investing activities is $102.92 M

What is Albireo Pharma TTM CFI year-on-year change?

Over the past year, ALBO TTM cash flow from investing activities has changed by -$103.88 M (-100.93%)